Transforming rheumatology models of care for Ontarians - Sunnybrook Health Sciences Centre

TorontoOntario's medical regulator has approved significant changes to the way doctors prescribe safer supply drugs, in an effort to reduce the amount of opioids making their way to the streets. Move is an effort to reduce amount of opioids making their way to the streets: regulatorLiam Casey · The Canadian Press · Posted: Oct 13, 2026 2:49 PM EDT | Last Updated: October 14Listen to this articleEstimated 4 minutesThe audio version of this article is generated by AI-based technology. Mispronunciations can occur. We are working with our partners to continually review and improve the results. The College of Physicians and Surgeons of Ontario's board of directors will soon implement several changes to the practice of prescribing safer supply, which are medications given to people at high risk of overdose as an alternative to illicit opioids. (Chris Young/The Canadian Press)Ontario's medical regulator approved significant changes Tuesday to the way doctors prescribe safer supply drugs, in an effort to reduce the amount of opioids making their way to the streets.

Among cancer patients, the high financial cost of cancer care is a prevalent problem. This financial burden is also associated with potentially harmful behavioral strategies that patients might use to cope with costs, such as delaying or forgoing treatment and skipping medications. Collectively, researchers refer to this impact as financial toxicity.

Continuous glucose monitors (CGMs) could transform diabetes management for millions of Americans with type 2 diabetes who don't take insulin, according to findings published in the New England Journal of Medicine. The clinical trial found that adults using CGMs spent approximately five additional hours each day within their target blood sugar range compared with those receiving routine care. Nearly twice as many CGM users also achieved an A1c level below 7%, a common treatment goal for people with diabetes.

Patients who wore noise-canceling headphones during minimally invasive gynecological surgery were significantly less likely to experience postoperative nausea and vomiting (PONV), suggest findings from a randomized clinical trial presented at the Anesthesiology 2026 annual meeting.